NCT03988946View on ClinicalTrials.gov

Cephea Transseptal Mitral Valve System FIH

NACompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Mitral Regurgitation
Interventions
DEVICE

Transcatheter Mitral Valve Replacement via Transseptal Access

The Cephea Transseptal Mitral Valve System is intended for use in symptomatic patients with moderate to severe degenerative or functional mitral regurgitation, who are poor candidates for surgery and who are anatomically eligible for the treatment.

Trial Locations (1)

Unknown

St. Vincent's Hospital, Sydney

Sponsors
All Listed Sponsors
lead

Cephea Valve Technologies

INDUSTRY